Anthera Pharmaceuticals Stock Market Value
| ANTH Stock | USD 0.0001 0.00 0.00% |
| Symbol | Anthera |
Anthera Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Anthera Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Anthera Pharmaceuticals.
| 11/27/2025 |
| 12/27/2025 |
If you would invest 0.00 in Anthera Pharmaceuticals on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Anthera Pharmaceuticals or generate 0.0% return on investment in Anthera Pharmaceuticals over 30 days. Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicine... More
Anthera Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Anthera Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Anthera Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1119 | |||
| Maximum Drawdown | 990.0 |
Anthera Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Anthera Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Anthera Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Anthera Pharmaceuticals historical prices to predict the future Anthera Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.089 | |||
| Jensen Alpha | 13.09 | |||
| Total Risk Alpha | 0.6076 | |||
| Treynor Ratio | (3.98) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anthera Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Anthera Pharmaceuticals Backtested Returns
Anthera Pharmaceuticals is out of control given 3 months investment horizon. Anthera Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for sixteen different technical indicators, which can help you to evaluate if expected returns of 12.86% are justified by taking the suggested risk. Use Anthera Pharmaceuticals Mean Deviation of 28.16, standard deviation of 114.14, and Risk Adjusted Performance of 0.089 to evaluate company specific risk that cannot be diversified away. Anthera Pharmaceuticals holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -3.23, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Anthera Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Anthera Pharmaceuticals is expected to outperform it. Use Anthera Pharmaceuticals treynor ratio and rate of daily change , to analyze future returns on Anthera Pharmaceuticals.
Auto-correlation | 0.00 |
No correlation between past and present
Anthera Pharmaceuticals has no correlation between past and present. Overlapping area represents the amount of predictability between Anthera Pharmaceuticals time series from 27th of November 2025 to 12th of December 2025 and 12th of December 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Anthera Pharmaceuticals price movement. The serial correlation of 0.0 indicates that just 0.0% of current Anthera Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Anthera Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Anthera Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Anthera Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Anthera Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Anthera Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Anthera Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Anthera Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Anthera Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Anthera Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Anthera Pharmaceuticals Lagged Returns
When evaluating Anthera Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Anthera Pharmaceuticals pink sheet have on its future price. Anthera Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Anthera Pharmaceuticals autocorrelation shows the relationship between Anthera Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Anthera Pharmaceuticals.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Anthera Pink Sheet
Anthera Pharmaceuticals financial ratios help investors to determine whether Anthera Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Anthera with respect to the benefits of owning Anthera Pharmaceuticals security.